Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 851 Lung Neoplasms 575 Small Cell Lung Carcinoma 164 Colorectal Neoplasms 130 Breast Neoplasms 104 Melanoma 100 Neoplasms 91 Ovarian Neoplasms 89 Neoplasm Metastasis 82 Pancreatic Neoplasms 74 Squamous Cell Carcinoma of Head and Neck 68 Stomach Neoplasms 59 Carcinoma, Renal Cell 54 Head and Neck Neoplasms 53 Esophageal Neoplasms 48 Triple Negative Breast Neoplasms 47 Endometrial Neoplasms 47 Prostatic Neoplasms 45 Uterine Cervical Neoplasms 41 Colonic Neoplasms 40 Urinary Bladder Neoplasms 39 Mesothelioma 38 Carcinoma, Hepatocellular 35 Mesothelioma, Malignant 34 Brain Neoplasms 30 Sarcoma 28 Carcinoma, Transitional Cell 28 Adenocarcinoma of Lung 28 Lung Diseases 24 Disease 24

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable NSCLC × Thoracic × 90 days × Clear all

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡